{Reference Type}: Evaluation Study
{Title}: [Dissecting cellulitis of the scalp: a retrospective study of 7 cases confirming the efficacy of oral isotretinoin].
{Author}: Koudoukpo C;Abdennader S;Cavelier-Balloy B;Gasnier C;Yédomon H;
{Journal}: Ann Dermatol Venereol
{Volume}: 141
{Issue}: 8
{Year}: Aug-Sep 2014
{Factor}: 0.934
{DOI}: 10.1016/j.annder.2014.06.007
{Abstract}: <B>BACKGROUND: </B>Dissecting cellulitis of the scalp (DCS) is a rare and long-standing disease and its aetiopathogenesis remains unclear. Various therapeutic alternatives exist. We attempted to assess the efficacy of oral isotretinoin in a series of patients.<BR><B>METHODS: </B>Seven cases of DCS followed and treated by one of the authors at the Sabouraud Centre in the Saint-Louis Hospital between 2007 and 2013 were retrospectively studied and the efficacy of oral isotretinoin was evaluated.<BR><B>RESULTS: </B>The seven patients included were males aged between 22 and 39 years, with alopecic nodules on the occiput (two cases) or the top of the vertex (five cases). Most patients were given oral isotretinoin at a dosage of 0.75mg/kg/day for at least nine months. The outcome was satisfactory with complete healing of the lesions and good regrowth in all cases. Follow-up after recovery lasted between 16 and 42 months.<BR><B>CONCLUSIONS: </B>Based on published studies and the results of the present study, oral isotretinoin at a dose of 0.75mg/kg/day may be proposed as first-line treatment for DCS.